Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors Meeting Abstract
| Authors: | Plummer, R.; Sanborn, R. E.; de Vries, E. G. E.; Lorusso, P.; Arkenau, H. T.; Uboha, N.; Wydmanski, J.; Fidler, M. J.; Boni, V.; Garcia-Corbacho, J.; Humphrey, R.; Will, M.; Autio, K. A.; El-Khoueiry, A. B.; Menke-van der Houven van Oordt, C. W.; Thistlethwaite, F. |
| Abstract Title: | Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy279.423 |
| Language: | English |
| ACCESSION: | WOS:000459277301020 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy279.423 |
| Notes: | Meeting Abstract: 436P -- Appears on page viii143 of the abstract book -- Source: Wos |
